H Tang et al., [52] showed in a network meta-analysis, the current evidence shows that the relationship between inhibitors of SUs, DPP-4i, GLP-1RA or SGLT2 and the risk of DR in DM patients is unclear. This evidence concerns the gene SLC5A2 and diabetes mellitus.